Research Articles - QUALIblood

Marie Didembourg, Sara Reda, Johannes Oldenburg, Heiko Rühl, Jonathan Douxfils, Laure Morimont

Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study

Int J Lab Hematol . 2024 Jan 31.

Bareille, M. et al.

Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.

J Clin Med 10, 1740 (2021).

Douxfils, J. et al. 2021

Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.

Thrombosis and haemostasis 121, 1008-1020 (2021).

Haguet, H. et al.

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study.

Frontiers in pharmacology 11, 1007 (2020).

Foidart, J. M. et al.

The Benefits of Estetrol Addition to Drospirenone for Contraception.

AJOG Global Reports (2023).

Douxfils, J., Beaudart, C. & Dogne, J.-M.

Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant. The Lancet (2023). https://doi.org:10.1016/S0140-6736(23)01634-3

The Lancet (2023).

Gillot, C. et al.

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.

Vaccines (Basel) 10, 2056 (2022).

Gerard, C. et al.

Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause.

Expert Rev Clin Pharmacol 15, 121-137 (2022).

Siriez, R.

Overcoming issues in plasmatic evaluation of direct Factor Xa inhibitors

PhD in Biomedical and Pharmaceutical Sciences thesis, University of Namur, (2022).

Gillot, C. et al.

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.

Frontiers in pharmacology 12, 708302 (2021).

Morimont, L. et al.

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

Biomolecules 12 (2022).

Haguet, H., Graux, C., Mullier, F., Dogne, J. M. & Douxfils, J.

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis.

Cancers (Basel) 12 (2020).

Ronvaux, L. et al.

Liquid Biopsy in Glioblastoma.

Cancers (Basel) 14 (2022).

Dechamps, M. et al.

Inflammation-induced coagulopathy substantially differs between COVID-19 and septic shock: a prospective observational study.

Frontiers in Medicine (2021).

Morimont, L.

Hormone-induced coagulopathy – Evaluation of the prothrombotic state using a global coagulation assay

PhD in Biomedical and Pharmaceutical Sciencesæ thesis, University of Namur, (2023).

Pouplard, M. et al.

Évaluation et prise en charge du risque thrombotique chez les patients hospitalisés atteints de Covid-19.

Hémato-Onco 14, 38-43 (2020).

Foidart, J. M. et al.

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study.

Journal of Clinical Medicine 12, 3928 (2023).

Douxfils, J., ten Cate, H. & Pola, R.

Editorial: Insights in thrombosis: 2022.

Frontiers in Cardiovascular Medicine 10 (2023).

Dechamps, M. et al.

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill.

International Journal of Molecular Sciences 24, 7278 (2023).

Barco, S. et al.

Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.

Thrombosis and haemostasis 119, 675-684 (2019).

Siriez, R. et al.

Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma.

International journal of laboratory hematology 41, 250-261 (2019).

Wauthier, L. et al.

D-dimer testing: A narrative review.

(2023).

Martini, A. et al.

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis.

TH Open 5, e438-e448 (2021).

Wauthier, L. et al.

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.

Diagnostics (Basel) 12, 2770 (2022).

Morimont, L., Gaspard, U., Foidart, J. M., Dogné, J.-M. & Douxfils,

Contraceptifs oraux combinés et thrombo-embolie veineuse: quels sont vriament les risques?

J. in Medi-Sphere Vol. 701 39-48 (2022).

Morimont, L., Haguet, H., Dogne, J. M., Gaspard, U. & Douxfils, J.

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.

Front Endocrinol (Lausanne) 12, 769187 (2021).

Haguet, H. et al.

Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.

J Med Virol 93, 3277-3281 (2021).

Reda, S., Morimont, L., Douxfils, J. & Ruhl, H.

Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?

Hamostaseologie 40, 364-378 (2020).

Haguet, H. et al.

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

TH Open 2, e68-e88 (2018).

Haguet, H.

Association of cardiovascular occlusive events with BCR-ABL tyrosine kinase therapy – Identification, understanding and prediction.

PhD in Biomedical and Pharmaceutical Sciences thesis, University of Namur, (2022).

Favresse, J. et al.

Andexanet alfa for the reversal of factor Xa inhibitors.

Expert Opin Biol Ther 19, 387-397 (2019).

Gemzell-Danielsson, K. et al.

A novel estetrol-containing combined oral contraceptive: European expert panel review.

Eur J Contracept Reprod Health Care 27, 373-383 (2022).